Ehave, Inc. Files to List on the Canadian Stock Exchange and Applies to Upgrade to OTCQB Exchange
04 janv. 2021 08h30 HE
|
Ehave
MIAMI, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics and developer of KetaDASH, a home delivery platform for patients who have...
Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value
28 déc. 2020 08h30 HE
|
Ehave
MIAMI, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics and developer of KetaDASH, a home delivery platform for patients who have...
Ehave KetaDASH Subsidiary Announces Intent to Battle Major Depression through Home Delivery of Ketamine
23 déc. 2020 08h30 HE
|
Ehave
Ketamine, originally approved by the FDA for anesthesia and pain relief, is now one of the psychedelics compounds being studied to treat mental health conditions like anxiety, addiction, and...
Ehave, Inc. Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021
17 déc. 2020 08h30 HE
|
Ehave
MIAMI, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients, announces...
Ehave, Inc. Announces KetaDASH for Ketamine Home Delivery and Purchase of Curedash Assets
16 déc. 2020 08h30 HE
|
Ehave
MIAMI, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients, today...
Ehave, Inc. and Identity Key Announce Partnership for Blockchain Based Identity Verification Software for the Medical Industry
07 déc. 2020 09h00 HE
|
Ehave
MIAMI, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced...
Ehave Dashboard Enters Final Simulations of Clinical Trials with the Hospital for Sick Children
04 déc. 2020 09h00 HE
|
Ehave
The Ehave Dashboard has the ability to segment data on-chain, which will allow developers, clinicians, researchers, doctors, hospitals, and universities to provide life-changing solutions to patients....
Ehave's Dashboard to Meet the Challenge of Electronic Health Records Security with BurstIQ Partnership Utilizing Blockchain Technology
09 nov. 2020 09h15 HE
|
Ehave
A recent report released by the Cybersecurity and Infrastructure Security Agency, part of the Department of Homeland Security, notes that the FBI and the Department of Health and Human Services have...
Ehave Expands Its Psychedelic Mental Health Platform with Medchart, a Leader in Medical Record Software, as a Plugin to the Ehave Dashboard
20 oct. 2020 08h45 HE
|
Ehave
MIAMI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to healthcare patients,...
PsyTech Hosts Live Investor Conference & Webinar October 27, 2020 and Closes Transaction with One of the Largest Psychedelic Conferences PsyTech.biz
25 sept. 2020 09h37 HE
|
Ehave
PsyTech Summit 2020 will be a one-day, international event bringing together decision makers, investors, clinicians, thought leaders, and advocates for the purpose of advancing psychedelics science,...